Results 21 to 30 of about 47 (47)

Disfunktsiya shchitovidnoy zhelezy i beremennost'

Гинекология, 2001
Щитовидная железа (ЩЖ), другие эндокринные железы, совместно с нервной и иммунной системами координирует и регулирует деятельность всех других систем организма, позволяя адекватно реагировать на постоянно изменяющиеся условия внешней и внутренней среды ...
T M Varlamova, A N Kerova, I Yu Abud, O E Ozerova, M M Shekhtman   +4 more
doaj  

[Thyrotoxicosis in a patient with Turner syndrome: radioactive iodine therapy]. [PDF]

Probl Endokrinol (Mosk), 2022
Guseinova RM, Prosvirnina AA, Korchagina MO, Trukhin AA, Sheremeta MS.   +4 more
europepmc   +1 more source

[Alemtuzumab-induced Graves' disease]. [PDF]

Probl Endokrinol (Mosk), 2023
Sheremeta MS, Korchagina MO, Guseinova RM, Schmidt TE, Nizhegorodova KS, Sviridenko NY, Melnichenko GA.   +6 more
europepmc   +1 more source

Clinical-diagnostic value of studying of the intima-media complex and the level of molecules of adhesion slCAM-1 and sVCAM-1 in patients with diabetes mellitus type 2 with clinical hyperthyroidism

Кубанский научный медицинский вестник, 2014
43 patients (9 male and 34 female) with diabetes mellitus of the second type with clinical hyperthyroidism at the age of 45-60 (the average age is 52,47±5,57 years) have been examined with the aim of studying the dependence between the thickness of ...
S. G. Kasatkina, T. N. Panova, S. N. Kasatkin   +2 more
doaj  

[Epidemiology of benign thyroid disorders in the adult population of the Republic of Belarus: analysis of nationwide statistics 2009 to 2019]. [PDF]

Probl Endokrinol (Mosk), 2022
Yakubouski SU, Kandratsenka HH, Salko OB, Kuz'menkova EI.   +3 more
europepmc   +1 more source

[Nodular toxic goiter in children: clinical features, morphological variants]. [PDF]

Probl Endokrinol (Mosk), 2021
Ivannikova TE, Bezlepkina OB, Abdulhabirova FM, Abrosimov AU, Degtyarev MV, Zubkova NA.   +5 more
europepmc   +1 more source

[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)]. [PDF]

Probl Endokrinol (Mosk), 2021
Troshina EA, Panfilova EA, Mikhina MS, Kim IV, Senyushkina ES, Glibka AA, Shifman BM, Larina AA, Sheremeta MS, Degtyarev MV, Rumyanstsev PO, Kuznetzov NS, Melnichenko GA, Dedov II.   +13 more
europepmc   +1 more source

[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development]. [PDF]

Probl Endokrinol (Mosk), 2023
Ermolaeva AS, Fadeev VV.
europepmc   +1 more source

[Radiotheranostics in endocrinology and oncoendocrinology]. [PDF]

Probl Endokrinol (Mosk), 2021
Rumyanstsev RO.
europepmc   +1 more source

[Dynamics of epidemiological indicators of thyroid pathology in the population of the Russian Federation: analytical report for the period 2009-2018]. [PDF]

Probl Endokrinol (Mosk), 2021
Troshina EA, Platonova NM, Panfilova EA.
europepmc   +1 more source